Name
KALAMAJA PEREARSTID Osaühing
Registry code
10825977
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
07.01.2002 (22)
Financial year
01.01-31.12
Capital
2 560.00 €
Activity
86211 - Provision of general medical treatment
898 940 €
114 944 €
13%
2 586 €
(estimate is approximate)
288 071 €
12
Submitted
No tax arrears
40%
30%
Owner | Representative | Beneficial owner | Roles | |
---|---|---|---|---|
Ene Loitme 08.12.1954 (69) | 50% - 1 280.00 EUR | Board member | Direct ownership | Founder |
Olga Anufrienko 05.01.1968 (56) | 50% - 1 280.00 EUR | Board member | Direct ownership | Founder |
Eha Kaevats 27.10.1951 (72) | - | - | Direct ownership | Founder |
Anne Toompuu 25.10.1969 (54) | - | - | - | Founder |
Merike Rätsep 29.07.1963 (61) | - | - | - | Founder |
2019 30.03.2020 | 2020 15.04.2021 | 2021 21.04.2022 | 2022 20.04.2023 | 2023 20.03.2024 | |
---|---|---|---|---|---|
Total Revenue | 719 684 € | 773 001 € | 859 870 € | 974 573 € | 898 940 € |
Net profit (loss) for the period | 79 100 € | 65 874 € | 71 690 € | 81 916 € | 114 944 € |
Profit Margin | 11% | 9% | 8% | 8% | 13% |
Current Assets | 109 112 € | 147 162 € | 204 552 € | 235 921 € | 294 234 € |
Fixed Assets | 34 388 € | 39 589 € | 35 770 € | 113 261 € | 93 373 € |
Total Assets | 143 500 € | 186 751 € | 240 322 € | 349 182 € | 387 607 € |
Current Liabilities | 29 853 € | 37 230 € | 49 111 € | 52 304 € | 45 861 € |
Non Current Liabilities | - | - | - | 63 751 € | 53 675 € |
Total Liabilities | - | - | - | 116 055 € | 99 536 € |
Share Capital | - | - | - | - | - |
Equity | 113 647 € | 149 521 € | 191 211 € | 233 127 € | 288 071 € |
Employees | 13 | 13 | 13 | 13 | 12 |
Turnover | State taxes | Labor taxes and payments | Employees | |
---|---|---|---|---|
2024 Q1 | - | 48 566.02 € | 50 215.08 € | 13 |
2023 Q4 | - | 59 848.76 € | 60 844.06 € | 13 |
2023 Q3 | - | 47 688.01 € | 49 213.38 € | 13 |
2023 Q2 | - | 55 282.75 € | 44 566.3 € | 12 |
2023 Q1 | - | 48 515.41 € | 50 062.18 € | 12 |
2022 Q4 | - | 48 509.78 € | 50 329.24 € | 13 |
2022 Q3 | - | 65 611.46 € | 68 062.9 € | 12 |
2022 Q2 | - | 55 265.27 € | 49 654.99 € | 12 |
2022 Q1 | - | 57 521.19 € | 59 718.79 € | 14 |
2021 Q4 | - | 43 544.74 € | 44 312.2 € | 14 |
2021 Q3 | - | 60 758.89 € | 63 659.71 € | 14 |
2021 Q2 | - | 52 051.94 € | 49 167.44 € | 14 |
2021 Q1 | - | 44 348.3 € | 46 195.01 € | 14 |
2020 Q4 | - | 53 459.72 € | 55 934.14 € | 13 |
2020 Q3 | - | 46 660.38 € | 48 875.01 € | 13 |
2020 Q2 | - | 43 952.04 € | 45 940.02 € | 13 |
2020 Q1 | - | 51 703.61 € | 48 430.24 € | 12 |